Physician
Oncology
Dr. Philip A. Dy, MD
|
|
Give Review
Philip practices Oncology. Doctor Philip A. Dy, MD is a published doctor. He published 2 publications, including: 'Phase II Study Of The Oral MEK Inhibitor Selumetinib In Advanced Acute Myeloid Leukemia (AML): A University Of Chicago Phase II Consortium Trial.' Philip A. Dy accepts all Medicare patients.
Publications
- Phase II Study Of The Oral MEK Inhibitor Selumetinib In Advanced Acute Myeloid Leukemia (AML): A University Of Chicago Phase II Consortium Trial.
- Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2(-) Locally ...
Schools
University Of Santo Tomas
Harlem Hospital Center
Temple University Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Temple University Hospital -
Harlem Hospital Center -
University of Santo Tomas
Drug Facts
| NPI NUMBER | 1710076567 | |
| NPPES Provider LastName | DY | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 62401 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2628.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 388.0 | |
| Percent Opioid Claims | 14.76 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710076567 |
| Last Name Of The Provider | DY |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Hong Chen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hanna M. Saba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Wade III, MD |
|
|
Dr. Shabbir H. Safdar, MD
This Doctor is OpenDoctor Recommended.
|